Skip to main content

Advertisement

Log in

New evidence on supplier-induced demand in China’s public tertiary hospitals: is the cost of hospitalization higher in the off-season?

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Supplier-induced demand (SID) is a long-standing concern in health economics and health system studies; however, empirical evidence on SID—critical to the development of health policy—is difficult to obtain, especially from China. This study, therefore, aims to add new evidence on SID in China’s public tertiary hospitals and facilitates the development of evidence-based health policies in China and other countries with similar healthcare systems. For this study, we used patient-level electronic medical records (EMRs) collected from the information systems of tertiary hospitals in a western province in China. From 11 tertiary hospitals, we collected 274,811 hospitalization records dated between 15 February and 30 November 2019. Total expenditure on hospitalization and length of admission of each patient were the primary metrics for measuring SID. We constructed a character indicator to measure the high-season or off-season status of hospitals, and log-linear estimations were applied to estimate the “off-season effect” on hospitalized expenditures and length of admission. We find that the cost of hospitalization is indeed higher in the off-season in China’s public tertiary hospitals; specifically, expenditures for patients admitted in the off-season increased by an average of 5.3–7.9% compared to patients admitted in the peak season, while the length of admission in the hospital increased by an average of 6.8% to 10.2%. We also checked the robustness of our findings by performing subgroup analyses of EMRs in the city-level hospitals and surgical group. We name this phenomenon the “hospital off-season effect” and suggest that the main reason for it is inappropriate financial incentives combined with a Fee-For-Services payment method. We suggest that China should work to reform inappropriate financial incentives in public hospitals to eliminate SID by changing its payment and financing compensation system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data used in this study originates from the Health Information Center of X Province. Restrictions on the availability of this data and therefore it is not publicly available, it is available from the corresponding authors on reasonable request.

References

  1. Arrow, K.J.: Uncertainty and the welfare economics of medical care. Am. Econ. Rev. 53, 941–973 (1963)

    Google Scholar 

  2. McGuire, T.G.: Chapter 9 physician agency. In: Handbook of health economics, pp. 461–536. Elsevier, Cham (2000)

    Google Scholar 

  3. Labelle, R., Stoddart, G., Rice, T.: A re-examination of the meaning and importance of supplier-induced demand. J. Health Econ. 13, 347–368 (1994). https://doi.org/10.1016/0167-6296(94)90036-1

    Article  CAS  PubMed  Google Scholar 

  4. De Jaegher, K., Jegers, M.: A model of physician behaviour with demand inducement. J. Health Econ. 19, 231–258 (2000). https://doi.org/10.1016/S0167-6296(99)00029-6

    Article  PubMed  Google Scholar 

  5. van Dijk, C.E., van den Berg, B., Verheij, R.A., Spreeuwenberg, P., Groenewegen, P.P., de Bakker, D.H.: Moral hazard and supplier-induced demand: empirical evidence in general practice: moral hazard and supplier-induced demand. Health Econ. 22, 340–352 (2013). https://doi.org/10.1002/hec.2801

    Article  PubMed  Google Scholar 

  6. Shih, Y.-C.T., Tai-Seale, M.: Physicians’ perception of demand-induced supply in the information age: a latent class model analysis. Health Econ. 21, 252–269 (2012). https://doi.org/10.1002/hec.1710

    Article  PubMed  Google Scholar 

  7. Kaiser, B., Schmid, C.: Does physician dispensing increase drug expenditures? empirical evidence from Switzerland: physician dispensing. Health Econ. 25, 71–90 (2016). https://doi.org/10.1002/hec.3124

    Article  PubMed  Google Scholar 

  8. Seyedin, H., Afshari, M., Isfahani, P., Hasanzadeh, E., Radinmanesh, M., Bahador, R.: The main factors of supplier-induced demand in health care: a qualitative study. J Edu Health Promot. 10, 49 (2021). https://doi.org/10.4103/jehp.jehp_68_20

    Article  Google Scholar 

  9. Ikegami, K., Onishi, K., Wakamori, N.: Competition-driven physician-induced demand. J. Health Econ. 79, 102488 (2021). https://doi.org/10.1016/j.jhealeco.2021.102488

    Article  PubMed  Google Scholar 

  10. Bhatia, M., Dwivedi, L.K., Banerjee, K., Dixit, P.: An epidemic of avoidable caesarean deliveries in the private sector in India: is physician-induced demand at play? Soc Sci Med 265, 113511 (2020). https://doi.org/10.1016/j.socscimed.2020.113511

    Article  CAS  PubMed  Google Scholar 

  11. Yu, J., Qiu, Y., He, Z.: Is universal and uniform health insurance better for China? Evidence from the perspective of supply-induced demand. HEPL 15, 56–71 (2020). https://doi.org/10.1017/S1744133118000385

    Article  PubMed  Google Scholar 

  12. Zhang, H., Hu, H., Wu, C., Yu, H., Dong, H.: Impact of China’s public hospital reform on healthcare expenditures and utilization: a case study in ZJ province. PLoS ONE 10, e0143130 (2015). https://doi.org/10.1371/journal.pone.0143130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhang, Y., Zhou, Z., Si, Y.: When more is less: what explains the overuse of health care services in China? Soc Sci Med 232, 17–24 (2019). https://doi.org/10.1016/j.socscimed.2019.04.018

    Article  PubMed  Google Scholar 

  14. Zhou, M., Zhao, S., Fu, M.: Supply-induced demand for medical services under price regulation: evidence from hospital expansion in China. China Econ. Rev. 68, 101642 (2021). https://doi.org/10.1016/j.chieco.2021.101642

    Article  Google Scholar 

  15. NHS: About NHS hospital services. https://www.nhs.uk/nhs-services/hospitals/about-nhs-hospital-services/ (2023)

  16. Anderson, R.J., Boumbulian, P.J., Pickens, S.S.: The role of US public hospitals in urban health. Acad. Med. 79, 1162–1168 (2004). https://doi.org/10.1097/00001888-200412000-00008

    Article  PubMed  Google Scholar 

  17. Horwitz, J.R.: Making profits and providing care: comparing nonprofit, for-profit and government hospitals. Health Aff. 24, 790–801 (2005). https://doi.org/10.1377/hlthaff.24.3.790

    Article  Google Scholar 

  18. Neumann, B.R.: A statistically based method for identifying hospital classification criteria. Public Health Rep. 95, 232–242 (1980)

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Prinja, S., Singh, M.P., Aggarwal, V., Rajsekar, K., Gedam, P., Goyal, A., Bahuguna, P.: Impact of India’s publicly financed health insurance scheme on public sector district hospitals: a health financing perspective. Lancet Reg Health Southeast Asia 9, 1123 (2023). https://doi.org/10.1016/j.lansea.2022.100123

    Article  Google Scholar 

  20. National Health Commission of the People’s Republic of China: China Health Statistical Yearbook 2020, 4-4-1: Public Hospital Revenues and Expenses. Beijing: Peking Union Medical College Publishing House (2021)

  21. National Health Commission of the People’ s Republic of China: China Health Statistical Yearbook 2022, 4-4-1: Public Hospital Revenues and Expenses. Beijing: Peking Union Medical College Publishing House (2023)

  22. Zhao, D., Zhang, Z.: Qualitative analysis of direction of public hospital reforms in China. Front. Med. 12, 218–223 (2018). https://doi.org/10.1007/s11684-017-0534-7

    Article  PubMed  Google Scholar 

  23. Yip, W.C.-M., Hsiao, W., Meng, Q., Chen, W., Sun, X.: Realignment of incentives for health-care providers in China. Lancet 375, 1120–1130 (2010). https://doi.org/10.1016/S0140-6736(10)60063-3

    Article  PubMed  Google Scholar 

  24. He, A.J., Fan, Y., Su, R.: Seeking policy solutions in a complex system: experimentalist governance in China’s healthcare reform. Policy. Sci. 55, 755–776 (2022). https://doi.org/10.1007/s11077-022-09482-2

    Article  PubMed  PubMed Central  Google Scholar 

  25. Zhang, X., Lai, H., Zhang, L., He, J., Fu, B., Jin, C.: The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China. BMC Health Serv. Res. 20, 1058 (2020). https://doi.org/10.1186/s12913-020-05849-4

    Article  PubMed  PubMed Central  Google Scholar 

  26. Xu, J., Jian, W., Zhu, K., Kwon, S., Fang, H.: Reforming public hospital financing in China: progress and challenges. BMJ (2019). https://doi.org/10.1136/bmj.l4015

    Article  PubMed  PubMed Central  Google Scholar 

  27. Yang, W.: How does the pharmaceutical industry influence prescription? A qualitative study of provider payment incentives and drug remunerations in hospitals in Shanghai. HEPL 11, 379–395 (2016). https://doi.org/10.1017/S1744133116000086

    Article  PubMed  Google Scholar 

  28. Fu, H., Li, L., Yip, W.: Intended and unintended impacts of price changes for drugs and medical services: evidence from China. Soc Sci Med 211, 114–122 (2018). https://doi.org/10.1016/j.socscimed.2018.06.007

    Article  PubMed  Google Scholar 

  29. National Healthcare Security Administration: Statistical snapshot of the development of the medical insurance business in 2021 (In Chinese) http://www.gov.cn/guoqing/2022-03/23/content_5680879.htm

  30. Lai, Y., Fu, H., Li, L., Yip, W.: Hospital response to a case-based payment scheme under regional global budget: The case of Guangzhou in China. Soc Sci Med 292, 114601 (2022). https://doi.org/10.1016/j.socscimed.2021.114601

    Article  PubMed  Google Scholar 

  31. National Healthcare Security Administration: Notice of issuing the list of DRG/DIP payment demonstration sites (In Chinese). http://www.gov.cn/zhengce/zhengceku/2021-12/21/content_5663873.htm

  32. Yan, J., Lin, H.-H., Zhao, D., Hu, Y., Shao, R.: China’s new policy for healthcare cost-control based on global budget: a survey of 110 clinicians in hospitals. BMC Health Serv. Res. 19, 84 (2019). https://doi.org/10.1186/s12913-019-3921-8

    Article  PubMed  PubMed Central  Google Scholar 

  33. Li, X., Zhang, Y., Zhang, X., Li, X., Lin, X., Han, Y.: Effects of fee-for-service, diagnosis-related-group, and mixed payment systems on physicians’ medical service behavior: experimental evidence. BMC Health Serv. Res. 22, 870 (2022). https://doi.org/10.1186/s12913-022-08218-5

    Article  PubMed  PubMed Central  Google Scholar 

  34. Xi, X., Wang, E., Lu, Q., Chen, P., Wo, T., Tang, K.: Does an economic incentive affect provider behavior? Evidence from a field experiment on different payment mechanisms. J. Med. Econ. 22, 35–44 (2019). https://doi.org/10.1080/13696998.2018.1539399

    Article  PubMed  Google Scholar 

  35. Yip, W., Fu, H., Chen, A.T., Zhai, T., Jian, W., Xu, R., Pan, J., Hu, M., Zhou, Z., Chen, Q., Mao, W., Sun, Q., Chen, W.: 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet 394, 1192–1204 (2019). https://doi.org/10.1016/S0140-6736(19)32136-1

    Article  PubMed  Google Scholar 

  36. National Healthcare Security Administration: Statistical snapshot of the development of the medical insurance business in 2018 (In Chinese). http://www.nhsa.gov.cn/art/2019/6/30/art_7_1477.html

  37. Sun, X., Liu, X., Sun, Q., Yip, W., Wagstaff, A., Meng, Q.: The impact of a pay-for-performance scheme on prescription quality in rural China: P4P and prescription quality in rural China. Health Econ. 25, 706–722 (2016). https://doi.org/10.1002/hec.3330

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the National Natural Science Foundation of China, National Social Science Foundation of China and Health Commission of Shaanxi Province for providing fund and support.

Funding

This research was funded by National Natural Science Foundation of China (72104195), Major Project of National Social Science Foundation of China (20&ZD121), China Postdoctoral Science Foundation (2021M702577).

Author information

Authors and Affiliations

Authors

Contributions

C.S., S.L., and ZL.Z. designed the research and approved the final version; C.S. and QW.D. performed research, conducted the analysis, and drafted the paper; QW.D. provided assistance and suggestions for analysis and revision; all authors wrote and edited the paper.

Corresponding authors

Correspondence to Chi Shen, Sha Lai or Zhongliang Zhou.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 22 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, C., Deng, Q., Lai, S. et al. New evidence on supplier-induced demand in China’s public tertiary hospitals: is the cost of hospitalization higher in the off-season?. Eur J Health Econ (2023). https://doi.org/10.1007/s10198-023-01638-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10198-023-01638-y

Keywords

JEL Classification

Navigation